Oxford Biomedica

Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[2



Oxford Biomedica doesn’t publicly share any plans to support the goals


Oxford Biomedica doesn’t publicly declare any measurable commitments to support the goals


Oxford Biomedica publicly shares examples of positive environmental / social actions, but doesn’t say how these support the goals


Oxford Biomedica publicly shares environmental / social data, but doesn’t how this supports progress towards the goals


Oxford Biomedica shares information about involving its suppliers in environmental / social issues but doesn’t mention involving them in supporting the goals

Review date: 25 October 2020
Country: United Kingdom